期刊
CURRENT OPINION IN GASTROENTEROLOGY
卷 23, 期 3, 页码 268-274出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MOG.0b013e3280ec5113
关键词
diabetes; hepatitis C virus; hepatocellular carcinoma; therapy
Purpose of review This review primarily focuses on new developments in the prevention and treatment of hepatocellular carcinoma. Recent findings Molecular markers for tumor biology are still in development, but advances thus far are promising.,The Barcelona Clinic Liver Cancer (BCLC) staging system offers the best prognostic information in patients with hepatocellular carcinoma. While surgery remains the gold standard for the treatment of hepatocellular carcinoma, new methods are emerging with greater potential response, lower risk and lower cost. Percutaneous local ablative therapy has proved very effective. Chemoemobolization therapy in hepatocellular carcinoma has been effective in selected patients with improved survival reported in a large cohort. Summary New methods for the management,of hepatocellular-carcinoma need to continue to evolve. This includes more focused therapies to reduce tumor development or more effective adjuvants to promote positive pre and posttransplant response. With the advent of better treatment options due to a clearer understanding of the pathogenesis of hepatocellular carcinoma, there is hope that the seemingly insurmountable burden of this disease will come under better control.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据